BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Career Advice

  What to Do if You Think You’re About to Get Fired

  Perhaps you sense something just isn’t quite right, but you’re not sure what. Or, maybe you have a pretty good idea that your organization is slimming down and your role will be one of the first ones to go.

  February 14, 2019

   · 

  2 min read

   · 

  Editorial Staff
• Business

  Gotham Therapeutics Strengthens Board of Directors and Scientific Advisory Board

  Gotham Therapeutics, a biotechnology company developing a novel drug class targeting RNA-modifying proteins, today announced the appointment of Carlo Incerti, M.D., Ph.D. as an independent Board Member.

  February 14, 2019

   · 

  5 min read
• Business

  Ipsen Delivers Strong 2018 Results and Expects Continued Sales and Profit Growth in 2019

  Ipsen, a global specialty-driven biopharmaceutical group, today announced its financial results for the full year 2018.

  February 14, 2019

   · 

  45 min read
• Burning Rock announces the completion of the Series C financing of RMB 850 million and strives to build an international leading tumor precision medicine brand

  On February 14, 2019, Burning Rock held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 million.

  February 14, 2019

   · 

  6 min read
• Genetown

  Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

  Participation from Johnson & Johnson Innovation – JJDC, Novartis Institutes for BioMedical Research, Osage University Partners, and Vor Co-founder PureTech Health

  February 14, 2019

   · 

  3 min read
• Business

  Targovax ASA: Fourth Quarter and Full Year 2018 Results

  Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces its fourth quarter and full year 2018 results.

  February 14, 2019

   · 

  2 min read
• Business

  Indivior FY 2018 Financial Results

  FY 2018 Adjusted Financial Results In-Line with Guidance. FY 2019 SUBLOCADE™ Guidance Introduced.

  February 14, 2019

   · 

  78 min read
• Business

  BioArctic - Full Year Report January - December 2018

  BioArctic’s partner Eisai will initiate BAN2401 confirmatory Phase 3-study in early Alzheimer’s disease. AbbVie in-licensed the Parkinson portfolio

  February 14, 2019

   · 

  8 min read
• Business

  IRRAS AB (Publ) Year-end Report January-December 2018

  During the fourth quarter the company started the launch preparations in the US. Regional sales managers and marketing staff were hired. Contacts were established with hospitals and training of future users of IRRAflow started.

  February 14, 2019

   · 

  4 min read
• Business

  Alligator Bioscience AB Year-end Report 2018

  The bispecific drug candidate ATOR-1015 in clinical development

  February 14, 2019

   · 

  4 min read